Well, we've got a stable cell line for production:
Patrys Establishes Stable Cell Line for Production of PAT-DX1
https://www.patrys.com/site/market-announcements/2021/663%20Patrys%20Successfully%20Establishes%20PAT-DX1%20Stable%20Cell%20Line_10%20February%202021.pdf
Melbourne, Australia; 10 February 2021: Patrys Limited (ASX: PAB, “Patrys” or the Company), a therapeutic antibody development company, is pleased to announce it has selected an optimised stable cell line for its lead asset PAT-DX1. This important step allows the company to establish largescale production of PAT-DX1 deoxymab for final preclinical studies, first-in-man studies, and partnering activities.
- Forums
- ASX - By Stock
- PAB
- Ann: Response to ASX Query
Ann: Response to ASX Query, page-32
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.6¢ | $903 | 131.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 2116616 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 888130 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2116616 | 0.006 |
15 | 7449991 | 0.005 |
11 | 6764199 | 0.004 |
6 | 6065682 | 0.003 |
2 | 2770000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 888130 | 2 |
0.008 | 1661233 | 4 |
0.009 | 431000 | 1 |
0.010 | 396000 | 5 |
0.011 | 680000 | 2 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |